I Prescribe Coumadin® (Warfarin)

Thanks to easy-to-use and highly accurate testing devices, patients can now test their PT/INR levels at home. In 2008, Medicare approved PT/INR self testing for several conditions. Today, Medicare and many insurance providers cover up to 52 PT/INR self tests per year.

An Enhancement to Point of Care Testing
Patient self testing is an enhancement to point of care testing at regular office visits, not a replacement for it. Self testing allows patients taking blood thinning medication to play an active role in their Coumadin® (Warfarin) therapy by testing at home. Plus, Real-Time Diagnostics encourages compliance with weekly telephone reminders.

More Time in Therapeutic Range
When your patient self tests at home, you'll receive INR test results and trends via fax each week. This means you'll have more frequent opportunities to review INR data and make dosage adjustments aimed at keeping your patient within the therapeutic range. Published studies have shown more frequent PT/INR testing improves patient outcomes.

More Data. Less Effort.
We've found dosage changes with weekly testing are similar to, and in some cases less than, dosage changes with monthly testing. With self testing, you'll have four times the data to potentially catch out-of-range results — but it won't significantly increase the amount of time you or your staff spend communicating dosage changes.

Financial Impact for Your Practice
Medicare reimburses for physician review and interpretation of four PT/INR test results every 28 days. Medicare also reimburses your practice for patient self-test training conducted by a registered nurse — or you can have Real-Time Diagnostics take care of this training for you. Either way, patient self testing may actually have a positive financial impact on your practice!